OTC Markets OTCQX - Delayed Quote USD

Cresco Labs Inc. (CRLBF)

Compare
1.6500 +0.0100 (+0.61%)
At close: 3:39 PM EDT
Loading Chart for CRLBF
DELL
  • Previous Close 1.6400
  • Open 1.6300
  • Bid 1.6400 x 40000
  • Ask 1.6600 x 40000
  • Day's Range 1.6300 - 1.6700
  • 52 Week Range 1.0550 - 2.6500
  • Volume 63,430
  • Avg. Volume 439,863
  • Market Cap (intraday) 570.177M
  • Beta (5Y Monthly) 1.97
  • PE Ratio (TTM) --
  • EPS (TTM) -0.5100
  • Earnings Date Nov 13, 2024 - Nov 18, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.00

Cresco Labs Inc., together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company also offers cannabis flowers under the FloraCal brand; and chocolate and toffee confections and fruit-forward gummies under the Mindy's Edibles brand, as well as licenses the Kiva brand, which produces cannabis infused edibles, including chocolate confections, gummies, mints, and tarts. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company was incorporated in 1990 and is headquartered in Chicago, Illinois.

www.crescolabs.com

2,900

Full Time Employees

December 31

Fiscal Year Ends

Recent News: CRLBF

View More

Performance Overview: CRLBF

Trailing total returns as of 10/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CRLBF
21.68%
S&P/TSX Composite index
14.36%

1-Year Return

CRLBF
19.12%
S&P/TSX Composite index
24.98%

3-Year Return

CRLBF
81.56%
S&P/TSX Composite index
18.95%

5-Year Return

CRLBF
73.21%
S&P/TSX Composite index
46.95%

Compare To: CRLBF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CRLBF

View More

Valuation Measures

Annual
As of 10/2/2024
  • Market Cap

    565.48M

  • Enterprise Value

    1.14B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.75

  • Price/Book (mrq)

    1.22

  • Enterprise Value/Revenue

    1.52

  • Enterprise Value/EBITDA

    82.54

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -23.47%

  • Return on Assets (ttm)

    4.81%

  • Return on Equity (ttm)

    -35.12%

  • Revenue (ttm)

    734.82M

  • Net Income Avi to Common (ttm)

    -172.46M

  • Diluted EPS (ttm)

    -0.5100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    112.3M

  • Total Debt/Equity (mrq)

    182.14%

  • Levered Free Cash Flow (ttm)

    58.06M

Research Analysis: CRLBF

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 181.18M
Earnings -54.33M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

3.00
3.00 Average
1.6500 Current
3.00 High
 

Company Insights: CRLBF

People Also Watch